Without a vaccine, the cost of reaching herd immunity during a pandemic is counted in lives lost, and it won’t quickly stop the virus’s spread.
Academic rigour, journalistic flair
Articles on Vaccines
Displaying 541 - 560 of 782 articles
If your immunisation record is incomplete, you might repeat a vaccination unnecessarily, or miss out on government support, child care, or work. So it pays to check.
Just focusing on spike proteins might not offer the complete immunity.
What happens when we have a COVID-19 vaccine – and millions are afraid of a needle?
There is a growing call for so-called challenge trials to speed up vaccine development.
Researchers are developing a seasonal shot that blocks Lyme disease-causing bacteria from a tick.
Early clinical trials into ginseng, rhubarb and rice paved the way for testing coronavirus treatments today.
Tobacco has imposed a terrible toll on global health, but it could be used to produce the molecules we need to fight COVID-19.
A unique challenge is emerging in the search for a COVID-19 vaccine: how to balance intellectual property rights with serving the public good.
Amazon and General Motors are among companies exploring ways to test employees for COVID-19 infection, but these measures may be against the law.
A potential vaccine for coronavirus is undergoing a human trial in Australia. It’s based on a vaccine that was already in development for influenza, and has shown promise in animal studies.
Long after a crisis recedes, residual anxiety can remain and become calcified in cultures, customs and institutions.
Results from phase 1 trials of a COVID-19 mRNA vaccine created a burst of optimism. But details the company failed to release suggest it is too early to speculate whether the vaccine is effective.
Do recent lockdown protests indicate that Australia is on the path to Trump’s America? While we can currently rest easy, the problem requires careful consideration.
Delaying medical care comes at a cost, both human and financial. The patients some emergency rooms have been seeing are a lot sicker and more likely to need hospitalization.
The UK is investing heavily in preparation for mass manufacturing of a working COVID-19 vaccine.
We don’t have vaccines for the Sars, Mers or the common cold. But that doesn’t mean scientists won’t crack it this time.
Army physicians are turning to drugs approved for other conditions or newly developed treatments such as the antiviral Remdesivir to treat infected personnel.
Vaccine development is usually a long process. The coronavirus pandemic is forcing researchers to innovate and test potential vaccines faster than ever before.
A vaccine historically used to prevent tuberculosis is now among the contenders for a COVID-19 vaccine. So what is the BCG vaccine and why might it work against coronavirus?
Top contributors
-
Professorial Fellow, University of Canberra
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor of Medicine, University of Virginia
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Associate Professor of Biology, Rochester Institute of Technology
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of Immunology, Vice-Chancellors Distinguished Professorial Fellow, Head of Immunology and Translational Research, Victoria University
-
Professor of Microbiology, School of Medicine, University of Washington
-
Lecturer in Virology, Queen's University Belfast
-
Professor of Immunology, RMIT University
-
Assistant Professor of Political Science, Oklahoma State University
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Professor, Discipline of Paediatrics and Child Health, University of Sydney
-
Senior Lecturer; MD, Victoria University
-
Associate Professor and ARC Future Fellow, The University of Western Australia
